Browse > Article
http://dx.doi.org/10.5351/KJAS.2009.22.2.341

Determination of Sample Sizes of Bivariate Efficacy and Safety Outcomes  

Lee, Hyun-Hak (Department of Biostatistics, Medical College, The Catholic University)
Song, Hae-Hiang (Department of Biostatistics, Medical College, The Catholic University)
Publication Information
The Korean Journal of Applied Statistics / v.22, no.2, 2009 , pp. 341-353 More about this Journal
Abstract
We consider sample-size determination problem motivated by comparative clinical trials where patient outcomes are characterized by a bivariate outcome of efficacy and safety. Thall and Cheng (1999) presented a sample size methodology for the case of bivariate binary outcomes. We propose a bivariate Wilcoxon-Mann-Whitney(WMW) statistics for sample-size determination for binary outcomes, and this nonparametric method can be equally used to determine sample sizes of ordinal outcomes. The two methods of sample size determination rely on the same testing strategy for the target parameters but differs in the test statistics, an asymptotic bivariate normal statistic of the transformed proportions in Thall and Cheng (1999) and nonparametric bivariate WMW statistic in the other method. Sample sizes are calculated for the two experimental oncology trials, described in Thall and Cheng (1999), and for the first trial example the sample sizes of a bivariate WMW statistic are smaller than those of Thall and Cheng (1999), while for the second trial example the reverse is true.
Keywords
Sample sizes; bivariate WMW; efficacy and safety;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Agresti, A. (1984). Analysis of Ordinal Categorical Data, John Wiley & Sons, New York
2 Birnbaum, Z. W. and Klose, O. M. (1957). Bounds for the variance of the Mann-Whitney statistic, The Annals of Mathematical Statistics, 28, 933-945   DOI   ScienceOn
3 Bryant, J. and Day, R. (1995). Incorporating toxicity considerations into the design of two-stage phase II clinical trials, Biometrics, 51, 1372-1383   DOI   ScienceOn
4 Conaway, M. R. and Petroni, G. R. (1995). Bivariate sequential designs for phase II trials, Biometrics, 51, 656-664   DOI   ScienceOn
5 Tubert-Bitter, P., Bloch, D. A. and Raynauld, J. (1995). Comparing the bivariate effects of toxicity and efficacy of treatments, Statistics in Medicine, 14, 1129-1141   DOI   ScienceOn
6 Petri, H., Leufkens, H., Naus, J., Silkens, R., van Hessen, P. and Urquhart, J. (1990). Rapid method for estimating the risk of acutely controversial side effects of prescription drugs, Journal of Clinical Epidemiology, 43,433-439   DOI   ScienceOn
7 Molenberghs, G. and Lesaffre, E. (1994). Marginal modeling of correlated ordinal data using a multivariate plackett distribution, Journal of the American Statistical Association, 89, 633-644   DOI   ScienceOn
8 Noether, G. E. (1987). Sample size determination for some common nonparametric tests, Journal of the American Statistical Association, 82, 645-647   DOI   ScienceOn
9 Norwood, P. K. and Sampson, A. R. (1988). A statistical methodology for postmarketing surveillance of adverse drug reaction reports, Statistics in Medicine, 7, 1023-1030   DOI   ScienceOn
10 Pocock, S. J., Geller, N. L. and Tsiatis, A. A. (1987). The analysis of multiple endpoints in clinical trials, Biometrics, 43, 487-498   DOI   ScienceOn
11 Thall, P. F. and Russell, K. E. (1998). A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase 1/11 clinical trials, Biometrics, 54, 251-264   DOI   ScienceOn
12 Simonoff, J. S., Hochberg, Y. and Reiser, B. (1986). Alternative estimation procedures for Pr(X < Y) in categorized data, Biometrics, 42, 895-907   DOI   ScienceOn
13 Thall, P. F. and Cheng, S. C. (1999). Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials, Biometrics, 55, 746-753   DOI   ScienceOn
14 Thall, P. F. and l.achin, J. M. (1988). Analysis of recurrent events:Nonparametric methods for randominterval count data, Journal of the American Statistical Association, 83, 339-347   DOI   ScienceOn
15 Conaway, M. R and Petroni, G. R (1996). Designs for phase II trials allowing for a trade-off between response and toxicity, Biometrics, 52, 1375-1386   DOI   ScienceOn
16 Cook, R J. and Farewell, V. T. (1994). Guidelines for monitoring efficacy and toxicity responses in clinical trials, Biometrics, 50, 1146-1152   DOI   ScienceOn
17 Cook, R J. (1996). Coupled error spending functions for parallel bivariate sequential tests, Biometrics, 52, 442-450   DOI   ScienceOn
18 Delong, E. R, Delong, D. M. and Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach, Biometrics, 44, 837-845   DOI   ScienceOn
19 Hochberg, Y. (1981). On the variance estimate of a Wilcoxon-Mann-Whitney statistic for group ordered data, Communications in Statistics - Theory and Method, A10, 1719-1732   DOI   ScienceOn
20 Jennison, C. and Turnbull, B. W. (1993). Group sequential tests for bivariate response: Interim analysis of clinical trials with both efficacy and safety endpoints, Biometrics, 49, 741-752   DOI   ScienceOn
21 Lehmann, E. L. (1975). Nonparametrics: Statistical Methods Based on Ranks, Holden-Day, San Francisco
22 Levine, M. N., Guyatt, G. H., Gent, M., De Pauw, S., Goodyear, M. D., Hryniuk, W. M., Arnold, A., Findlay, B., Skillings, J. R. and Bramwell, V. H. (1988). Quality of life in stage II breast cancer: An instrument for clinical trials, Journal of Clinical Oncology, 6, 1798-1810   DOI
23 Lipsitz, S. R., laird, N. M. and Harrington, D. P. (1990). Maximum likelihood regression methods for paired binary data, Statistics in Medicine, 9, 1517-1525   DOI   ScienceOn